The Journal of Heart and Lung Transplantation
Volume 22, Issue 11 , Pages 1183-1200 , November 2003

A review of lung transplant donor acceptability criteria

  • Jonathan B Orens, MD

      Affiliations

    • Johns Hopkins University, Baltimore, Maryland, USA
    • Corresponding Author InformationReprint requests: Jonathan B. Orens, MD, Johns Hopkins University, 600 North Wolfe Street, Blalock 910, Baltimore, Maryland 21287, USA. Telephone: 410-955-3467. Fax: 410-955-0036.
    • ,
  • Annette Boehler, MD

      Affiliations

    • University Hospital, Zurich, Switzerland
    • ,
  • Marc de Perrot, MD

      Affiliations

    • Toronto General Hospital, Toronto, Ontario, Canada
    • ,
  • Marc Estenne, MD

      Affiliations

    • Erasme Hospital, Brussels, Belgium
    • ,
  • Allan R Glanville, MD, FRACP

      Affiliations

    • St. Vincent’s Hospital, Sydney, Australia
    • ,
  • Shaf Keshavjee, MD

      Affiliations

    • Toronto General Hospital, Toronto, Ontario, Canada
    • ,
  • Robert Kotloff, MD

      Affiliations

    • University of Pennsylvania, Philadelphia, Pennsylvania, USA
    • ,
  • Judith Morton, MBBS, FRACP

      Affiliations

    • St. Vincent’s Hospital, Sydney, Australia
    • ,
  • Sean M Studer, MD

      Affiliations

    • Mt. Sinai Medical Center, New York, New York, USA
    • ,
  • Dirk Van Raemdonck, MD, PhD

      Affiliations

    • University Hospital, Gasthuisberg, Leuven, Belgium
    • ,
  • Thomas Waddel, MD, MSc, PhD, FRCSC

      Affiliations

    • Toronto General Hospital, Toronto, Ontario, Canada
    • ,
  • Gregory I Snell, MBBS, FRACP

      Affiliations

    • Alfred Hospital, Prahran, Australia

Received 2 November 2002 ,Accepted 22 January 2003.

References 

  1. Pierre AF, Sekine Y, Hutcheon M, Waddell TK, Keshavjee S. Marginal lung donors (a reassessment). J Thorac Cardiovasc Surg. 2002;123(3):421–428
  2. Garrity ER. Pre-transplant evaluation of the donor/organ procurement. In: Norman DJ, Suki WN, editors. Primer on Transplantation first edition. Thorofare, N.J. American Society of Transplant Physicians, 1998, p. 499–505
  3. Myoshi S, Trulock EP, Shaefers H, Hsie C, Patterson GA, Cooper JD. Cardiopulmonary exercise testing after single and double lung transplantation. Chest. 1990;97:1130–1136
  4. United Network for Organ Sharing. Guidelines for multiorgan donor management and procurement. UNOS Update 1993;14–5
  5. Richter N, Raddatz G, Steinhoff G, Schafers HJ, Schlitt HJ. Transmission of donor lymphocytes in clinical lung transplantation. Transplant Int. 1994;7:414–419
  6. Grewe M. Chronological aging and photoaging of dendritic cells. Clin Exp Dermatol. 2001;26:608–612
  7. Rosas GO, Zierman SJ, Donabedian M, Vandegaer K, Hare JM. Augmented age-associated innate immune responses contribute to negative inotropic and lusitropic effects of lipopolysaccharide and interferon gamma. J Mol Cell Cardiol. 2001;33:1849–1859
  8. Pawelee G, Mariani E, Bradley B, Solana R. Longevity in vitro of human CD4+ T helper cell clones derived from young donors and elderly donors, or from progenitor cells (age associated differences in cell surface molecule expression and cytokine secretion). Biogerontology. 2000;1:247–254
  9. Novick RJ, Bennett LE, Meyer DM, Hosenpud JD. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant. 1999;18:425–431
  10. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Effect of donor age and ischemic time in intermediate survival and morbidity after lung transplantation. Chest. 2000;118:1255–1262
  11. Sommers KE, Griffith BP, Hardesty RL, Keenan RJ. Early lung allograft function in twin recipients from the same donor (risk factor analysis). Ann Thorac Surg. 1996;62:784–790
  12. Bhorade SM, Vigneswaran W, McCabe MA, Garrity ER. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant. 2000;19:1199–1204
  13. Sundaresan S, Semenkovich J, Ochoa L, et al.  Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg. 1995;109:1075–1079
  14. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The registry of the International Society for Heart and Lung Transplantation (eighteenth official report—2001). J Heart Lung Transplant. 2001;20:805–815
  15. Harjula A, Baldwin JC, Starnes VA, et al.  Proper donor selection for heart–lung transplantation. The Stanford experience. J Thorac Cardiovasc Surg. 1987;94:874–880
  16. Gabbay E, Williams TJ, Griffiths AP, et al.  Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med. 1999;160:265–271
  17. Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation. 1993;56:1418–1422
  18. Waller DA, Bennett MK, Corris PA, Dark JH. Donor-acquired fat embolism causing primary organ failure after lung transplantation. Ann Thorac Surg. 1995;59:1565–1566
  19. Simonetti VA, Basha MA, Allenspach L, Klosterman KG, Nakhleh R, Higgins RS. Donor cerebral tissue pulmonary emboli in a functioning transplanted lung. Clin Transplant. 1998;12:504–507
  20. Rosendale BE, Keenan RJ, Duncan SR, et al.  Donor cerebral emboli as a cause of acute graft dysfunction in lung transplantation. J Heart Lung Transplant. 1992;11:72–76
  21. Nguyen DQ, Salerno CT, Bolman M, Park SJ. Pulmonary thromboembolectomy of donor lungs prior to lung transplantation. Ann Thorac Surg. 1999;67:1787–1789
  22. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant. 1998;17:423–429
  23. Shumway SJ, Hertz MI, Petty MG, Bolman RM. Liberalization of donor criteria in lung and heart–lung transplantation. Ann Thorac Surg. 1994;57:92–95
  24. Puskas JD, Winton TL, Miller JD, Scavuzzo M, Patterson GA. Unilateral donor lung dysfunction does not preclude successful contralateral single lung transplantation. J Thorac Cardiovasc Surg. 1992;103:1015–1017
  25. el-Gamel AL, Egan L, Rahman A, Deiraniya AK, Yonan N. Application of pulmonary vein gas analysis (a novel approach which may increase the pool of potential lung transplant donors). J Heart Lung Transplant. 1996;15(3):315–316
  26. Frost AE. Donor criteria and evaluation. Clin Chest Med. 1997;18:231–237
  27. Meyers BF, Lynch J, Trulock EP, Guthrie JD, Patterson GA. Lung transplantation (a decade of experience). Ann Surg. 1999;230:362–370
  28. Cooper JD. The lung donor (special considerations). Transplant Proc. 1988;20:17–18
  29. Griffith BP, Zenati M. The pulmonary donor. Clin Chest Med. 1990;11:217–226
  30. Winton TL, Miller JD, Scavuzzo M, et al.  Donor selection for pulmonary transplantation. Transplant Proc. 1991;23:2472–2474
  31. Egan T. Selection and management of the lung donor. In:  Patterson GA,  Couraud L editor. Current topics in general thoracic surgery. Amsterdam: Elsevier; 1995;p. 103–115
  32. Egan T, Boychuk JE, Rosato K, et al.  Whence the lungs? A study to assess suitability of donor lungs for transplantation. Transplantation. 1992;53:420–422
  33. Hsieh AH, Bishop MJ, Kubilis PS, et al.  Pneumonia following closed head injury. Am Rev Respir Dis. 1992;146:290–294
  34. Van Raemdonck D, Roels L, Verleden G, et al. Whence the lungs? Assessment of the use of lungs for transplantation from 156 consecutive donors [abstract]. In: Cooper JD, Weder W, eds. Proceedings of the Third International Lung Transplant Symposium. 1993:40
  35. Riou B, Guesde R, Jacquens Y, et al.  Fiberoptic bronchoscopy in brain-dead organ donors. Am J Respir Crit Care Med. 1994;150:558–560
  36. Stewart S, Ciulli F, Wells FC, et al.  Pathology of unused donor lungs. Transplant Proc. 1993;25:1167–1168
  37. Low DE, Kaiser LE, Haydock DA, et al.  The donor lung (infectious and pathologic factors affecting outcome in lung transplantation). J Thorac Cardiovasc Surg. 1993;106:614–621
  38. Zenati M, Dowling RD, Dummer JS, et al.  Influence of the donor lung on development of early infections in lung transplant recipients. J Heart Lung Transplant. 1990;9:502–509
  39. Sole-Violan J, Rodriguez de Castro F, Rey A, et al.  Comparison of bronchoscopic diagnostic techniques with histological findings in brain dead organ donors without suspected pneumonia. Thorax. 1996;51:929–931
  40. Maurer JR, Tullis DE, Grossman RF, et al.  Infectious complications following isolated lung transplantation. Chest. 1992;101:1056–1059
  41. Dowling RD, Zenati M, Yousem SA, et al.  Donor-transmitted pneumonia in experimental lung allografts; successful prevention with donor antibiotic therapy. J Thorac Cardiovasc Surg. 1992;103:767–772
  42. Weill D, Dey GC, Young KR, et al.  A positive donor gram stain does not predict the development of pneumonia, oxygenation or duration of mechanical ventilation following lung transplantation. J Heart Lung Transplant. 2001;20:255
  43. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The registry of the International Society for Heart and Lung Transplantation (fourteenth official report—1997). J Heart Lung Transplant. 1997;16:691–694
  44. Snell GI, Rabinov M, Griffiths A, et al.  Pulmonary allograft ischemic time (an important predictor of survival after lung transplantation). J Heart Lung Transplant. 1996;15:169–174
  45. Gammie JS, Dtukus DR, Pham SM, et al.  Effect of ischemic time on survival in clinical lung transplantation. Ann Thorac Surg. 1999;68:2015–2020
  46. Fiser SM, Kron IL, Long SM, Kaza AK, Kern JA, Cassada DC, et al.  Influence of graft ischemic time on outcome following lung transplantation. J Heart Lung Transplant. 2001;20(12):1291–1296
  47. Kshettry VR, Kroshus T, Burdine J, Savik K, Bolman M. Does organ ischemia over four hours affect long-term survival after lung transplantation?. J Heart Lung Transplant. 1996;15:169–174
  48. Winton TL, Miller J, deHoyos A, Snell GI, Maurer JR. Graft function, airway healing, rejection, and survival in pulmonary transplantation are not affected by graft ischemia in excess of 5 hours. Transplant Proc. 1993;25(1):1649–1650
  49. Glanville AR, Marshman D, Keogh A, et al.  Outcome in paired recipients of single lung transplants from the same donor. J Heart Lung Transplant. 1995;14:878–882
  50. Wahlers T, Schafers HJ, Cremer J, et al.  Organ preservation for heart–lung and lung transplantation. J Thorac Cardiovasc Surg. 1991;39:344–348
  51. Ueno T, Snell GI, Williams TJ, et al.  Impact of graft ischemia time on outcomes after bilateral sequential single-lung transplantation. Ann Thorac Surg. 1999;67:1577–1582
  52. deHoyos A, Patterson GA, Maurer JR, Ramirez JC, Miller J, Winton TL. Pulmonary transplantation. Early and late results. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 1992;103:295–306
  53. Egan T. Lung preservation. Semin Thorac Cardiovasc Surg. 1992;4:83–89
  54. Knight SR, Dresler C. Results of lung transplantation. Semin Thorac Cardiovasc Surg. 1992;4:107–112
  55. Fischer S, Matte-Martyn A, de Perot M, Waddell TK, Sekine Y, Hutcheon M, et al.  Low potassium dextran preservation solution improves lung function after human lung transplantation. J Thorac Cardiovasc Surg. 2001;121(3):594–596
  56. Lillehei CW, Shamberger RC, Mayer JE, Burke RP, Koka BV, Arnold J, et al.  Size disparity in pediatric lung transplantation. J Pediatr Surg. 1994;29:1152–1155
  57. Loring SH, Leith DE, Connolly MJ, Ingenito EP, Mentzer SJ, Reilly JJ. Model of functional restriction in chronic obstructive pulmonary disease, transplantation, and lung reduction surgery. Am J Respir Crit Care Med. 1999;160:821–828
  58. Massard G, Badier M, Guillot C, Reynaud M, Thomas P, Giudicelli R. Lung size matching for double lung transplantation based on the submammary thoracic perimeter. Accuracy and functional results. J Thorac Cardiovasc Surg. 1993;105:9–14
  59. Otulana BA, Mist BA, Scott JP, Wallwork J, Higgenbottam T. The effect of recipient lung size on lung physiology after heart–lung transplantation. Transplantation. 1989;48:625–629
  60. Tamm M, Higgenbottam T, Dennis CM, Sharples LD, Wallwork J. Donor and Recipient predicted lung volume and lung size after heart–lung transplantation. Am J Respir Crit Care Med. 1994;150:403–407
  61. Lloyd KS, Barnard P, Holland VA, Noon GP, Lawrence EC. Pulmonary function after heart-lung transplantation using larger donor organs. Am Rev Respir Dis. 1990;142:1026–1029
  62. Miyoshi S, Schaefers HJ, Trulock EP, Yamazaki F, Schreinemakers H, Patterson GA, et al.  Donor selection for single and double lung transplantation. Chest size matching and other factors influencing posttransplantation vital capacity. Chest. 1990;98:308–313
  63. Park SJ, Houck J, Pifarre R, Sullivan H, Garrity ER, Kim SY, et al.  Optimal size matching in single lung transplantation. J Heart Lung Transplant. 1995;14:671–675
  64. Hayden AM, Scarlett MV, Fox K. Relationship between donor/recipient lung size mismatch and functional outcome in single lung transplantation for COPD. J Transplant Coord. 1996;6:155–158
  65. Wisser W, Klepetko W, Wekerle T, Laufer G, Stift A, Hiesmayr M, et al.  Tailoring of the lung to overcome size disparities in lung transplantation. J Heart Lung Transplant. 1996;15:239–242
  66. Egan T, Thompson JT, Detterbeck FC, Lackner RP, Mill MR, Ogden WD, et al.  Effect of size (mis)matching in clinical double-lung transplantation. Transplantation. 1995;59:707–713
  67. Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement (assessment and operative technique). Ann Thorac Surg. 1993;56:1409–1413
  68. Husain AN, Hinkamp TJ. Donor lung pathology (correlation with outcome of transplanted contralateral lung). J Heart Lung Transplant. 1993;12:932–939
  69. Speziali G, McDougall JC, Midthun DE, Peters SG, Scott JP, Daly RC, et al.  Native lung complications after single lung transplantation for emphysema. Transplant Int. 1997;10:113–115
  70. Svendsen CA, Bengston RB, Park SJ, Shumway SJ. Stage 1 adenocarcinoma presenting in the pneumonectomy specimen at the time of single lung transplantation. Transplantation. 1998;66:1108–1109
  71. Choi YH, Leung AN, Miro S, Poirier C, Hunt S, Theodore J. Primary bronchogenic carcinoma after heart or lung transplantation (radiologic and clinical findings). J Thorac Imag. 2000;15:36–40
  72. Delcambre F, Pruvot FR, Ramon P, Noel C, Pol A, Jaillard-Thery S, et al.  Primary bronchogenic carcinoma in transplant recipients. Transplant Proc. 1996;28:2884–2885
  73. DeSoyza AG, Dark JH, Parums DV, Curtis A, Corris PA. Donor acquired small cell lung cancer following pulmonary transplantation. Chest. 2001;120:1030–1031
  74. Stagner LD, Allenspach L, Hogan K, Willcock L, Higgins RS, Chan K. Bronchogenic carcinoma in lung transplant recipients. J Heart Lung Transplant. 2001;20:908–911
  75. Arcasoy SM, Hersch C, Christie JD, Zisman D, Pochettino A, Rosengard BR, et al.  Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant. 2001;20:1044–1053
  76. Warner MA, Offord KP, Warner ME, Lennon RL, Conover MA, Jansson-Schumacher U. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications (a blinded prospective study of coronary artery bypass patients). Mayo Clin Proc. 1989;64:609–616
  77. Nakagawa M, Tanaka H, Tsukuma H, Kishi Y. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest. 2001;120:705–710
  78. Dales RE, Dionne G, Leech JA, Lanau M, Schweitzer I. Preoperative prediction of pulmonary complications following thoracic surgery. Chest. 1993;104:155–159
  79. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking (40 years’ observations on male British doctors). BMJ. 1994;309:901–911
  80. Lam TH, Ho SY, Hedley AJ, Mark KH, Peto R. Mortality and smoking in Hong Kong (case-control study of all adult deaths in 1998). BMJ. 1998;323:1–6
  81. Liaw KM, Chen CJ. Mortality attributable to cigarette smoking in Taiwan (a 12-year follow-up study). Tobacco Control. 1998;7:141–148
  82. Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, et al.  Emerging tobacco hazards in China (1). BMJ. 1998;317:1411–1422
  83. Wald NJ, Watt HC. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. BMJ. 1997;314:1860–1863
  84. Xu X, Dockery DW, Ware JH, Speizer FE, Ferris BGJ. Effects of cigarette smoking on rate of loss of pulmonary function in adults (a longitudinal assessment). Am Rev Respir Dis. 1992;146:1345–1348
  85. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ. 1977;1:1645–1648
  86. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1 (the Lung Health Study). JAMA. 1994;272:1497–1505
  87. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, et al.  Smoking cessation and lung function in mild–moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:381–390
  88. Penn I. Transmission of cancer from organ donors. Ann Transplant. 1997;2:7–12
  89. Detry O, Honore P, Hans MF, Delbouille MH, Jacquet N, Meurisse M. Organ donors with primary central nervous system tumor. Transplantation. 2000;70:244–248
  90. Healy PJ, Davis CL. Transmission of tumours by transplantation. Lancet. 1998;352:2–3
  91. Chui AK, Herbertt K, Wang LS, Kyd G, Hodgeman G, Verran DJ, et al.  Risk of tumor transmission in transplantation from donors with primary brain tumors (an Australian and New Zealand Registry report). Transplant Proc. 1999;31:1266–1267
  92. Kauffman HM, McCabe MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry. Transplantation. 2000;70:1747–1751
  93. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation. 1995;59:480–485
  94. Buell JF, Trofe J, Hanaway MJ, Lo A, Rosengard BR, Rilo H, et al.  Transmission of donor cancer into cardiothoracic transplant recipients. Surgery. 2001;130:660–668
  95. Barrou B, Bitker MO, Delcourt A, Ourahma S, Richard F. Fate of a renal tubulopapillary adenoma transmitted by an organ donor. Transplantation. 2001;72:540–542
  96. Penn I. Donor transmitted disease (cancer). Transplant Proc. 1991;23:2629
  97. Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion. 1998;38:975–988
  98. Starzl TE, Tzakis A, Makowka L, et al.  The definition of ABO factors in transplantation (relation to other humoral antibody states). Transplant Proc. 1987;19:4492–4497
  99. Hunt BJ, Yacoub M, Amin S, et al.  Induction of red blood cell destruction by graft-derived antibodies after minor ABO-mismatched heart and lung transplantation. Transplantation. 1988;1988:246–249
  100. Salerno CT, Burdine J, Perry EH, et al.  Donor-derived antibodies and hemolysis after ABO-compatible but nonidentical heart–lung and lung transplantation. Transplantation. 1998;65:261–264
  101. Taaning E, Morling N, Mortensen SA, et al.  Hemolytic anemia due to graft-derived anti-B production after lung transplantation. Transplant Proc. 1994;26:1739
  102. Magrin GT, Street AM, Williams TJ, et al.  Clinically significant anti-A derived from B lymphocytes after single lung transplantation. Transplantation. 1993;56:466–467
  103. Cummins D, Contreras M, Amin S, et al.  Red cell alloantibody development associated with heart and lung transplantation. Transplantation. 1995;59:1432–1435
  104. Yu NC, Haug MT, Khan SU, et al.  Does the donor–recipient ABO blood group compatibility status predict subsequent lung transplantation outcomes?. J Heart Lung Transplant. 1999;18:764–768
  105. Novick RJ, Schafers HJ, Stitt L, et al.  Recurrence of obliterative bronchiolitis and determinants of outcome in 139 pulmonary retransplant recipients. J Thorac Cardiovasc Surg. 1995;110:1402–1413
  106. Ghosh S, Latimer R, Tew D. Airway obstruction in lungs obtained from an asthmatic donor complicating heart–lung transplantation. Anesthesiology. 1990;73:1270–1271
  107. Corris PA, Dark JH. Aetiology of asthma (lessons learned from lung transplantation). Lancet. 1993;341:1369–1371
  108. Morrison JFJ, Higgenbottam T, Hathaway TJ, et al.  Diumal variation in FEV1 after heart–lung transplantation. Eur Respir J. 1992;5:834–840
  109. Higgenbottam T. Lung transplantation and asthma [letter]. Lancet. 1993;342:249
  110. Stanbrook MB, Kesten S. Bronchial hyperreactivity after lung transplantation predicts early bronchiolitis obliterans. Am J Respir Crit Care Med. 1999;160:2034–2039
  111. Kotloff RM. Personal communication; 2002
  112. Torres A, El-Ebiary, Rano A. Respiratory infectious complications in the intensive care unit. Clin Chest Med 1999;20:287–301
  113. Ciulli F, Tamm M, Dennis CM, et al.  Donor transmitted bacterial infection after lung transplantation. Transplant Proc. 1993;25:1155
  114. Ciccone AM, Stewart KC, Meyers BF, Guthrie TJ, Battafarano RJ, Trulock EP, et al.  Does donor cause of death affect the outcome of lung transplantation?. J Thorac Cardiovasc Surg. 2002;123(3):429–434
  115. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation . 2000 annual report of the U.S. Scientific Registry for transplant recipients and the organ procurement and transplantation network. Washington, DC: UNOS; 2000;
  116. Waller DA, Thompson AM, Wrightson WN, Gould FK, Corris PA, Hilton CJ, et al.  Does the mode of donor death influence the early outcome of lung transplantation? A review of lung transplantation from donors involved in major trauma. J Heart Lung Transplant. 1995;14:318–321
  117. Da Silva JA. Sex hormones and glucocorticoids (interaction with the immune system). Ann NY Acad Sci. 1999;876:102–117
  118. Rohleder N, Schommer NC, Hellhammer DH, Engel R, Kirschbaum C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom Med. 2001;63:966–972
  119. McMurray RW, Ndebele K, Hardy KJ, Jenkins JK. 17-Beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine. 2001;14:324–333
  120. McElhinney DB, Khan JH, Babcock WD, Hall TS. Thoracic organ donor characteristics associated with successful lung procurement. Clin Transplant. 2001;15:68–71

PII: S1053-2498(03)00096-2

doi: 10.1016/S1053-2498(03)00096-2

The Journal of Heart and Lung Transplantation
Volume 22, Issue 11 , Pages 1183-1200 , November 2003

Article Tools

* Image Usage & Resolution